Juvenescence is an investment company that actively creates new ventures and directly invests in both startup and established companies focused on therapies to increase human longevity and related sectors. They have made 8 investments, including in companies like LyGenesis and Morphoceuticals, and often participate in 2-6 investment rounds annually, typically with deals in the $5-10 million range.
100% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-a (50% of deals).
Portfolio
2
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 LyGenesis, Inc. | Series A | $19M | Oct 2023 |
 Morphoceuticals Inc. | Unknown | $8M | Feb 2023 |
Top Co-Investors
Prime Movers Lab2 shared
Last updated: 28 April 2026